Therapeutic Asset Ratings

6,305 results matching 1 filter

91,565 assets7,904 sponsors3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
bt02 Plasma Cell Myeloma	Biotroy Therapeutics	P1/2	CC (45)
Bxq-350 Colorectal Carcinoma	Bexion Pharmaceuticals, Inc.	P1/2	CC (45)
Camizestrant Ovarian Serous Adenocarcinoma	AstraZeneca	P1/2	CC (45)
Camustine Plasmablastic Lymphoma	AIDS Malignancy Consortium	P1/2	CC (45)
Capecitabine Brain Neoplasm	Northwell Health	P1/2	CC (45)
Capivasertib Precursor B-Cell Acute Lymphoblastic Leukemia	Princess Maxima Center for Pediatric Oncology	P1/2	CC (45)
Capivasertib T Lymphoblastic Leukemia/Lymphoma	Princess Maxima Center for Pediatric Oncology	P1/2	CC (45)
Capivasertib Refractory Precursor T-Lymphoblastic Lymphoma/Leukemia	Princess Maxima Center for Pediatric Oncology	P1/2	CC (45)
car19tif cells B-Cell Non-Hodgkin Lymphoma	Chinese PLA General Hospital	P1/2	CC (45)
Car-20/19-T Cells Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma	Medical College of Wisconsin	P1/2	CC (45)
Car.70/Il15-Transduced Cb-Nk Cells Acute Myeloid Leukemia	M.D. Anderson Cancer Center	P1/2	CC (45)
Carbon Nanoparticle-Loaded Iron Thyroid Cancer	Sichuan Enray Pharmaceutical Sciences Company	P1/2	CC (45)
Carbon Nanoparticle-Loaded Iron Neoplasm	Sichuan Enray Pharmaceutical Sciences Company	P1/2	CC (45)
Carboplatin Astrocytoma, IDH-Mutant, Grade 2	Neonc Technologies, Inc.	P1/2	CC (45)
Carboplatin IDH-Wildtype Glioblastoma	Neonc Technologies, Inc.	P1/2	CC (45)
Carboplatin Cutaneous Neuroendocrine Carcinoma	Neonc Technologies, Inc.	P1/2	CC (45)
Catequentinib Soft Tissue Sarcoma	Sarcoma Oncology Research Center, LLC	P1/2	CC (45)
cd123-car-nk cells Acute Myeloid Leukemia	Chongqing Precision Biotech Co., Ltd	P1/2	CC (45)
CD123-CAR T Acute Myeloid Leukemia	Shenzhen Geno-Immune Medical Institute	P1/2	CC (45)
cd123-cd33 ccar t cells Acute Myeloid Leukemia	Essen Biotech	P1/2	CC (45)
cd19car-cd3zeta-4-1bb-expressing autologous t-lymphocyte cells B-Cell Non-Hodgkin Lymphoma	University of Colorado, Denver	P1/2	CC (45)
cd19- specific car engineered autologous t-cells Acute Lymphoblastic Leukemia	St. Jude Children's Research Hospital	P1/2	CC (45)
cd19 specific chimeric antigen receptor t cell Primary Mediastinal Large B-Cell Lymphoma	Pell Bio-Med Technology Co., Ltd.	P1/2	CC (45)
cd19-ucart Adult Acute Lymphoblastic Leukemia	University Hospital Heidelberg	P1/2	CC (45)
cd22 car-transduced t cells Primary Central Nervous System Lymphoma	Essen Biotech	P1/2	CC (45)

Showing 3026 to 3050 of 6,305 assets

PreviousPage 122 of 253Next